{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:04:17Z","timestamp":1792789457314,"version":"4.5.0"},"reference-count":40,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Azole resistance in Aspergillus fumigatus is most frequently conferred by mutations in the cyp51A gene encoding 14\u03b1-sterol demethylases. TR34\/L98H and TR46\/Y121F\/T289A are the two most common mutations associated with environmental resistance selection. We studied the minimal inhibitory concentration (MIC) distribution of clinical A. fumigatus isolates to characterize the Clinical and Laboratory Standards Institute (CLSI) susceptibility profiles of isolates with the wild-type (WT) cyp51A genotype, and isolates with the TR34\/L98H and TR46\/Y121F\/T289A cyp51A mutations. Susceptibility testing was performed according to CLSI M38-A2. The MICs of 363 A. fumigatus isolates were used in this study. Based on the CLSI epidemiological cut-off values (ECVs), 141 isolates were phenotypically non-WT and 222 isolates had a phenotypically WT susceptibility. All isolates with the TR34\/L98H mutation had an itraconazole MIC &gt; 1 mg\/L which is above the CLSI ECV. Eighty-six of 89 (97%) isolates with the TR34\/L98H mutation had voriconazole and posaconazole MICs above the CLSI ECV, i.e., MICs of 1 and 0.25 mg\/L, respectively. The isolates with a TR46\/Y121F\/T289A mutation showed a different phenotype. All 37 isolates with a TR46\/Y121F\/T289A mutation had a voriconazole MIC above the CLSI ECV, while 28\/37 (76%) isolates had an itraconazole MIC &gt; 1 mg\/L. Interestingly, only 13 of 37 (35%) isolates had a posaconazole MIC &gt; 0.25 mg\/L.<\/jats:p>","DOI":"10.3390\/jof4030103","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T02:49:34Z","timestamp":1535597374000},"page":"103","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates"],"prefix":"10.3390","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4031-0778","authenticated-orcid":false,"given":"Jochem B.","family":"Buil","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands"},{"name":"Center of Expertise in Mycology Radboudumc\/CWZ, 6525 Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-1916","authenticated-orcid":false,"given":"Ferry","family":"Hagen","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, 6532 Nijmegen, The Netherlands"},{"name":"Department of Medical Mycology, Westerdijk Fungal Biodiversity Institute, 3584 Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-7462","authenticated-orcid":false,"given":"Anuradha","family":"Chowdhary","sequence":"additional","affiliation":[{"name":"Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi 110021, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8600-9860","authenticated-orcid":false,"given":"Paul E.","family":"Verweij","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands"},{"name":"Center of Expertise in Mycology Radboudumc\/CWZ, 6525 Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3253-6080","authenticated-orcid":false,"given":"Jacques F.","family":"Meis","sequence":"additional","affiliation":[{"name":"Center of Expertise in Mycology Radboudumc\/CWZ, 6525 Nijmegen, The Netherlands"},{"name":"Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, 6532 Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: Can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-resistant aspergillosis: Epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/mmy\/myx144","article-title":"Triazole resistance surveillance in Aspergillus fumigatus","volume":"56","author":"Lagrou","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nmni.2015.04.005","article-title":"First detection of Aspergillus fumigatus azole-resistant strain due to cyp51A TR46\/Y121F\/T289A in an azole-naive patient in Spain","volume":"6","author":"Pelaez","year":"2015","journal-title":"New Microbes New Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","author":"Camps","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007\u20132009","volume":"17","author":"Snelders","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Meis, J.F., Chowdhary, A., Rhodes, J.L., Fisher, M.C., and Verweij, P.E. (2016). Clinical implications of globally emerging azole resistance in Aspergillus fumigatus. Phil. Trans. R. Soc. Lond. B Biol. Sci., 371.","DOI":"10.1098\/rstb.2015.0460"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lestrade, P.P., Bentvelsen, R.G., Schauwvlieghe, A.F.A.D., Schalekamp, S., van der Velden, W.J., Kuiper, E.J., van Paassen, J., van der Hoven, B., van der Lee, H.A., and Melchers, W.J. (2018). Voriconazole resistance and mortality in invasive aspergillosis: A multicenter retrospective cohort study. Clin. Infect. Dis., in press.","DOI":"10.1093\/cid\/ciy859"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","author":"Verweij","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"ref_12","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2017). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, CLSI. [3rd ed.]. M38-A2."},{"key":"ref_13","unstructured":"European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2015). Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal Agents for Conidia Forming Moulds, EUCAST. E. Def. 9.3, EUCAST definitive document."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dku364","article-title":"Azole, polyene and echinocandin mic distributions for wild-type, TR34\/L98H and TR46\/Y121F\/T289A Aspergillus fumigatus isolates in the Netherlands","volume":"70","author":"Rijs","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/AAC.39.2.314","article-title":"Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi","volume":"39","author":"Dawson","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1128\/AAC.05959-11","article-title":"Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating Cyp51A sequence analysis","volume":"56","author":"Meletiadis","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. For the CLSI broth microdilution method (M38-A2 document)","volume":"48","author":"Diekema","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jac\/dkq041","article-title":"Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands","volume":"65","author":"Klaassen","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jgar.2015.01.005","article-title":"Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: Is it de novo or environmentally acquired?","volume":"3","author":"Sharma","year":"2015","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations","volume":"51","author":"Mellado","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e00791-00717","DOI":"10.1128\/mBio.00791-17","article-title":"A novel environmental azole resistance mutation in Aspergillus fumigatus and a possible role of sexual reproduction in its emergence","volume":"8","author":"Zhang","year":"2017","journal-title":"mBio"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13693780802545600","article-title":"Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery","volume":"47","author":"Hodiamont","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/CMR.00095-16","article-title":"Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species","volume":"4","author":"Dudakova","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1128\/AAC.01279-12","article-title":"Posaconazole pharmacodynamic target determination against wild-type and cyp51 mutant isolates of Aspergillus fumigatus in an in vivo model of invasive pulmonary aspergillosis","volume":"57","author":"Lepak","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1128\/AAC.00931-09","article-title":"Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene","volume":"54","author":"Mavridou","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Camps, S.M., Dutilh, B.E., Arendrup, M.C., Rijs, A.J., Snelders, E., Huynen, M.A., Verweij, P.E., and Melchers, W.J. (2012). Discovery of a hape mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050034"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Gsaller, F., Hortschansky, P., Furukawa, T., Carr, P.D., Rash, B., Capilla, J., Muller, C., Bracher, F., Bowyer, P., and Haas, H. (2016). Sterol biosynthesis and azole tolerance is governed by the opposing actions of SrbA and the CCAAT binding complex. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1006106"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e02101-16","DOI":"10.1128\/AAC.02101-16","article-title":"Screening and characterization of a non-cyp51A mutation in an Aspergillus fumigatus cox10 strain conferring azole resistance","volume":"61","author":"Wei","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jac\/dkt075","article-title":"The cdr1b efflux transporter is associated with non-cyp51A-mediated itraconazole resistance in Aspergillus fumigatus","volume":"68","author":"Fraczek","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1128\/EC.00171-13","article-title":"Contributions of Aspergillus fumigatus atp-binding cassette transporter proteins to drug resistance and virulence","volume":"12","author":"Paul","year":"2013","journal-title":"Eukaryot. Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/mmy\/myw005","article-title":"Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance","volume":"54","author":"Meneau","year":"2016","journal-title":"Med. Mycol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Chen, Y., Li, Z., Han, X., Tian, S., Zhao, J., Chen, F., Su, X., Zhao, J., Zou, Z., and Gong, Y. (2018). Elevated MIC values of imidazole drugs against Aspergillus fumigatus isolates with TR34\/L98H\/A297T\/F495I mutation. Antimicrob. Agents Chemother., 62.","DOI":"10.1128\/AAC.01549-17"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Buil, J.B., van der Lee, H.A.L., Rijs, A., Zoll, J., Hovestadt, J., Melchers, W.J.G., and Verweij, P.E. (2017). Single-center evaluation of an agar-based screening for azole resistance in Aspergillus fumigatus by using vipcheck. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.01250-17"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/jac\/dkx319","article-title":"Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus","volume":"72","author":"Arendrup","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/JCM.02478-15","article-title":"First detection of TR34 L98H and TR46 Y121F T289A cyp51 mutations in Aspergillus fumigatus isolates in the United States","volume":"54","author":"Wiederhold","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/jac\/dkw323","article-title":"PCR-based detection of Aspergillus fumigatus cyp51A mutations on bronchoalveolar lavage: A multicentre validation of the AsperGenius assay(r) in 201 patients with haematological disease suspected for invasive aspergillosis","volume":"71","author":"Chong","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fmicb.2018.00515","article-title":"Molecular detection of azole-resistant Aspergillus fumigatus in clinical samples","volume":"9","author":"Buil","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/myc.12702","article-title":"PCR-based detection of Aspergillus fumigatus and absence of azole resistance due to TR34\/L98H in a French multicenter cohort of 137 patients with fungal rhinosinusitis","volume":"61","author":"Morio","year":"2018","journal-title":"Mycoses"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1128\/JCM.01032-17","article-title":"Molecular diagnosis of invasive aspergillosis and detection of azole resistance by a newly commercialized PCR kit","volume":"55","author":"Dannaoui","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fgb.2018.02.003","article-title":"In-host microevolution of Aspergillus fumigatus: A phenotypic and genotypic analysis","volume":"113","author":"Ballard","year":"2018","journal-title":"Fungal Genet. Biol."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/4\/3\/103\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:21:52Z","timestamp":1760196112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/4\/3\/103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["jof4030103"],"URL":"https:\/\/doi.org\/10.3390\/jof4030103","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]}}}